ANSUVIMAB

3 reported adverse events

Drug classes: Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]

ANSUVIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EBOLA DISEASE 1 0.0588
1 POSTPARTUM HAEMORRHAGE 1 0.0007
2 LOW BIRTH WEIGHT BABY 1 0.0001
3 PREMATURE DELIVERY 1 0.0001
4 PREMATURE BABY 1 0.0000
5 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
6 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
7 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
8 OFF LABEL USE 1 0.0000
See all enriched reactions for ANSUVIMAB